Allchorne, Paula <br/><br/>
Initial experience of intravesical gemcitabine for patients with high-risk superficial transitional cell carcinoma of the bladder following BCG failure.  [electronic resource] 

 -  Urologic nursing   
 - 95-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1053-816X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravesical<br/>Aged<br/>Aged, 80 and over<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>BCG Vaccine--therapeutic use<br/>Carcinoma, Transitional Cell--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--prevention & control<br/>Risk Factors<br/>Treatment Failure<br/>Urinary Bladder Neoplasms--drug therapy<br/>Gemcitabine